Skip to main content

Table 1 Baseline Characteristics of Randomised participants

From: Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial

Characteristic Study population (N = 27)
Age (yrs.) 24.5 (8.1)
Sex
 Female 10 (37%)
 Male 17 (63%)
Ethnic Origin
 Māori 4 (15%)
 NZ European 20 (74%)
 Other 3 (11%)
History of allergic rhinitis 14 (51.9%)
Body-mass indexa 24.6 (3.5)
FEV1 before bronchodilation (% predicted) 87.7 (10.6)
Peak Expiratory Flow (l/min) 443 (99)
FeNO (ppb) 87 (42–212)
Blood eosinophil count (× 10^9/L) 0.33 (0.18–1.18)
Blood eosinophil count ≥0.27 × 10^9/L 24 (88.9%)
Serum Periostin (ng/ml) 187.5 (109.4–442.5)
  1. Values are given as mean (SD), median (Range), or n (%). aThe body-mass index is the weight in kilograms divided by the square of the height in meters